Clinical trial
Study Investigating the Safety and Tolerability of Multiple Doses of PF-02545920…
NCT00463372 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00463372 |
|---|---|
| Title | Study Investigating the Safety and Tolerability of Multiple Doses of PF-02545920 in Subjects With Schizophrenia |
| Official title | A Phase I, Investigator And Subject-Blind (Sponsor Unblinded), Placebo-Controlled Dose Escalation Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Pf-02545920 After Multiple Oral Dose Administration In Subjects With Stable Schizophrenia |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Schizophrenia, Schizo-affective Disorder |
| Intervention type | Drug |
| Interventions | PF-02545920 |
| Enrollment | 40 |
| Start date | Oct 1, 2006 |
| Completion | May 1, 2007 |
| First posted | Apr 20, 2007 |
| Last update posted | Sep 5, 2018 |
| Countries | South Africa |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: